Symposium:
168. Successful Lineages and Plasmids—Emergence of Dissemination of Multidrug-Resistant Bacteria
Friday, October 9, 2015: 2:00 PM-3:30 PM
Room: 30--ABCDE

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • list three important subclones with E. coli ST131 and their key distinguishing features
  • describe and appraise the evidence for three possible reasons for the emergence of E. coli ST131
  • examine how Enterobacteriaceae utilize multiple mechanisms of genetic mobilization to create complex network of drug resistance
  • discuss insights into the population dynamics of gonococcus within hosts and populations and their implication for the biological basis and transmission of multidrug resistant gonorrhea

Target Audience: Scientists, Researchers, Public health practitioners, Microbiologists, Members-in-training, Lab personnel, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Pediatric ID, Investigative ID, Global ID, Epidemiology and Infection Control, Adult ID

Moderators:  Costi D. Sifri, MD, FIDSA, University of Virginia Health System and James R. Johnson, MD, FIDSA, FACP, FRCPE, University of Minnesota

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: No CPE credit is offered for this session

ACPE Number:

Disclosures:

C. D. Sifri, None

J. R. Johnson, Crucell: Consultant , Consulting fee
ICET: Consultant , Consulting fee
Merk: Investigator , Grant recipient
Tetraphase: Investigator , Grant recipient

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.